Marine Peptides intermediate
Marine Peptide Drug Candidates
Overview of marine-derived peptides in clinical development including anticancer, antiviral, and anti-inflammatory agents.
By Encyclopeptide Editorial | 1 min read
marine drug-candidate clinical-development natural-product peptide-drug
Approved Marine Peptide Drugs
| Drug | Source | Indication |
|---|---|---|
| Ziconotide | Conus snail venom | Severe pain |
| Trabectedin | Tunicate Ecteinascidia | Soft tissue sarcoma |
| Eribulin | Halichondria sponge | Breast cancer |
| Cytarabine | Sponge Tectitethya crypta | Leukemia (prodrug) |
Clinical Pipeline
| Compound | Source | Phase | Indication |
|---|---|---|---|
| Plitidepsin | Tunicate | 3 | T-cell lymphoma |
| Kahalalide F | Mollusk | 2 | Solid tumors |
| Bryostatin 1 | Bryozoan | 2 | Alzheimer’s |
Drug Discovery Challenges
- Sustainable sourcing (synthesis vs extraction)
- Structural complexity
- Supply chain reliability
Chemical Identity
| Property | Value |
|---|---|
| Name | Marine Peptide Drug Candidates |
| Category | Marine Peptides |
Biological Significance
This molecule plays important roles in biological systems and has potential therapeutic applications.
References
- Encyclopeptide Database. “Marine Peptide Drug Candidates” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Marine Peptide Drug Candidates with interactive quizzes on Wikipept.
Take a Quiz on Wikipept